AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Panfil IV Injection

Prescription Icon
Prescription Required

Marketer

Allegiant Biotech

Salt Composition

Pantoprazole (40mg)

Overview Panfil IV Injection

Acid-reducing medication, Panfil IV Injection, is intravenously administered by healthcare professionals to manage stomach acid overproduction. Indicated for conditions like acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, it alleviates symptoms and fosters healing. Prophylactic use includes preventing stress ulcers in critically ill patients and mitigating aspiration risks during anesthesia. Classified as a proton pump inhibitor (PPI), this injection is reserved for patients where oral administration isn't optimal. Dosage and treatment duration are determined by individual needs and response, requiring adherence to the prescribed regimen even with symptom resolution. Lifestyle modifications, such as smaller, more frequent meals and avoidance of caffeine, spicy foods, and fatty foods, enhance treatment efficacy. Common, typically mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, abdominal pain, and thrombophlebitis (vein inflammation). Persistent or bothersome side effects warrant medical attention. Prolonged use, particularly exceeding one year or at higher doses, may elevate bone fracture risk. Consult your doctor about preventative measures, such as calcium and vitamin D supplementation. Panfil IV Injection is contraindicated for individuals with severe hepatic impairment, those using HIV medications, those with a history of PPI allergy, or pre-existing osteoporosis. Pregnant or breastfeeding individuals, and those consuming alcohol (which exacerbates acid production), should seek medical guidance. Refrain from operating machinery if experiencing dizziness or drowsiness.

Uses of Panfil IV Injection

Management of gastroesophageal reflux disorder (GERD), peptic ulcers, and Zollinger-Ellison syndrome.

Major Benefits of Panfil IV Injection:

This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.

Common Side effects of Panfil IV Injection:

  • Diarrhea
  • Flatulence
  • Headache
  • Joint pain
  • Nausea
  • Stomach pain
  • Vomiting
  • Dizziness
  • Thrombophlebitis

How to use Panfil IV Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Panfil IV Injection works:

Panfil IV Injection, a proton pump inhibitor, decreases gastric acid production, thus alleviating symptoms of acid indigestion and heartburn.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol consumption alongside Panfil IV Injection is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Panfil IV Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Administration of Panfil IV Injection during lactation is likely safe. Available human data indicates minimal risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Panfil IV Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.

KidneyKidneySAFE IF PRESCRIBED

Panfil IV Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.

LiverLiverCAUTION

Patients with significant hepatic impairment should receive Panfil IV Injection with close monitoring. Dosage modification of Panfil IV Injection may be necessary. Physician consultation is advised.

What if you forget to take Panfil IV Injection :

Omitting a scheduled dose of Panfil IV Injection necessitates contacting your physician.

Facts to Know About Panfil IV Injection

LabelValue
Pharmaceutical Classification Benzimidazole sulfoxide analog
Addictive None.
Medication Classification Digestive system
Mechanism of Action Gastric acid secretion suppressants

FAQs on Panfil IV Injection

Intravenous Panfil is indicated for managing peptic ulcers, esophageal reflux, and gastroesophageal reflux disease (GERD). This injection mitigates the increased stomach acidity often caused by analgesic use. Furthermore, it's employed in the treatment of Zollinger-Ellison syndrome (ZES), a condition characterized by hyperacidity. Its mechanism of action involves decreasing gastric acid secretion, thereby alleviating associated symptoms.
Concurrent use of antacids and Panfil IV Injection is acceptable; administer antacids at least two hours prior to or following Panfil IV Injection administration.
Noticeable improvement should occur within 2 to 3 days. However, full therapeutic effect from Panfil IV Injection may require up to four weeks, meaning some symptoms might persist until then.
Prolonged Panfil IV Injection therapy, while infrequent, can sometimes lead to increased body weight. This may be attributed to improved reflux symptoms, potentially resulting in increased food consumption. Discuss any weight concerns with your physician.
Consuming alcohol while using Panfil IV Injection is not recommended. While alcohol doesn't directly interfere with Panfil IV Injection's mechanism, it can stimulate increased stomach acid, potentially exacerbating existing symptoms.
Administer Panfil IV Injection one hour prior to eating. Dietary restrictions include spicy and fatty foods. Consumption of caffeinated beverages, including tea, coffee, and cola, is prohibited. Alcohol should be avoided due to potential symptom exacerbation.
Intravenous Panfil is typically intended for brief treatment. Nevertheless, extended administration may be considered by a physician for conditions like peptic ulcers or Zollinger-Ellison syndrome. Prolonged therapy increases the potential for adverse reactions and necessitates careful medical oversight. Always adhere to your doctor's instructions and remain under their care when using Panfil IV Injection.
Concurrent use of analgesics and Panfil IV Injection is acceptable. Panfil IV Injection mitigates the risk of painkiller-induced gastric distress and ulcers. Panfil IV Injection should be administered one hour prior to meals, while analgesics are typically consumed with or following a meal to minimize stomach irritation.
A single dose of Panfil IV Injection may prove inadequate. Relief from symptoms is often achieved with just a few doses. This injection is typically prescribed for short-term use, up to two weeks, in managing heartburn, indigestion, and acid reflux. Longer-term administration might be necessary in cases like peptic ulcer disease or Zollinger-Ellison syndrome (ZES), as determined by a physician. If symptoms persist after two weeks of regular use as directed, seek medical advice.
Extended Panfil IV Injection use beyond three months can lead to adverse effects. Low blood magnesium is a primary concern, potentially causing fatigue, confusion, dizziness, tremors, or muscle spasms, and irregular heart rhythms. Prolonged administration exceeding one year increases the risk of bone fragility, gastrointestinal infections, and vitamin B12 deficiency. This deficiency can result in anemia, manifesting as increased fatigue, weakness, pallor, palpitations, dyspnea, lightheadedness, digestive upset, anorexia, flatulence, or neurological symptoms including numbness, tingling, and gait disturbances.
Panfil IV Injection
41
MRP 50
18% off